24 studies found for:    Open Studies | "Giant Cell Arteritis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Tocilizumab for Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Tocilizumab + Glucocorticoids (GCs);   Drug: Placebo + Glucocorticoids (GCs)
2 Not yet recruiting Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone
3 Not yet recruiting Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Condition: Giant Cell Arteritis
Intervention: Device: Ultrasound of temporal and axillary arteries
4 Not yet recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
5 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
6 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: prednisone;   Drug: prednisone placebo;   Drug: tocilizumab [RoActemra/Actemra];   Drug: tocilizumab placebo
7 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
8 Unknown  Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Betamethasone;   Drug: isotonic sodium chloride solution (placebo)
9 Unknown  Study of the T CD8 Immune Response in Horton's Disease
Condition: Horton's Disease
Interventions: Other: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment;   Other: 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment;   Other: Blood sample drawn into a 5 mL dry tube;   Other: 16 blood samples drawn into 6 mL heparinized tubes
10 Unknown  Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Conditions: Horton's Disease;   Infectious Disease;   Neoplasia;   Solid Tumor;   Hemopathy
Interventions: Other: 1 blood sample;   Other: 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)
11 Unknown  Diagnostic Study of Temporal Arteritis
Condition: Temporal Arteritis
Intervention:
12 Unknown  Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Conditions: Temporal Arteritis;   Duplex of Temporal Artery;   Biopsy of Temporal Artery
Intervention: Procedure: biopsy of temporal artery
13 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
14 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
15 Recruiting Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease
Condition: Horton Disease
Interventions: Radiation: Vascular tomodensitometry;   Other: Magnetic resonance angiography;   Other: Vascular ultrasonography;   Other: Retinal angiography;   Other: Retinal optical coherence tomography
16 Recruiting Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study.
Condition: Horton's Disease
Intervention: Drug: corticoids+ tocilizumab 8mg/Kg/month
17 Recruiting Impact of Vasculitis on Employment and Income
Conditions: Vasculitis;   Systemic Vasculitis;   Behcet's Disease;   CNS Vasculitis;   Cryoglobulinemic Vasculitis;   Eosinophilic Granulomatosis;   Temporal Arteritis;   Wegener Granulomatosis;   Henoch-Schoenlein Purpura;   Microscopic Polyangiitis;   Polyarteritis Nodosa (PAN);   Takayasu's Arteritis;   Urticarial Vasculitis
Intervention: Other: online questionnaire
18 Recruiting The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Condition: Juvenile Dermatomyositis
Interventions: Dietary Supplement: Creapure;   Dietary Supplement: Glucose Tablet
19 Recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
20 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)
Intervention: Drug: Baricitinib

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years